Table 1. Demographic/clinical information and laboratory data collected in the study population.
| Variables | Values |
|---|---|
| Demographic and clinical information | |
| Age, median (IQR) | 61.5 (80–62) |
| Female/Male | 43/34 |
| Coexisting morbidities, n (%) | |
| Any | 22 (28.5) |
| Hypertensive disorder | 17 (22) |
| Chronic renal disease | 8 (10.4) |
| Diabetes | 8 (10.3) |
| Dilated cardiomyopathy | 7 (9) |
| Chronic obstructive chronic disease | 7 (9) |
| Atrial fibrillation | 6 (7.8) |
| None | 2 (3) |
| Deaths, n (%) | 4 (5.2) |
| Laboratory data | |
| ADAMTS13 activity (U/dL), median (IQR) | 70 (80–60) |
| vWF:Ag (%), median (IQR) | 231.2 (415.3–205.7) |
| vWF:RCo (%), median (IQR) | 150.0 (334.3–116.9) |
| ADAMTS13/vWF:RCo, median (IQR) | 0.40 (0.50–0.23) |
| vWF:RCo/vWF:Ag, median (IQR) | 0.65 (0.87–0.6) |
| Factor VIII (%), median (IQR) | 95.20 (133.0–69.40) |
| D-dimer (ng/mL) | 882.0 (2250–460.0) |
| Hemoglobin (g/dL), median (IQR) | 11.9 (13.3–9.8) |
| Platelet count (×10 9 /L), median (IQR) | 234 (283–149) |
| White cell count (×10 9 /L), median (IQR) | 6.1 (9.4–4.5) |
| Lactate dehydrogenase (U/L), median (IQR) | 236.0 (314.5–197.0) |
| Creatinine (mg/dL), median (IQR) | 0.9 (1.5–0.6) |
| C-reactive protein (mg/L), median (IQR) | 1.7 (9.3–0.4) |
| Erythrocyte sedimentation rate (mm/h) | 34 (79.5–23.5) |
| Prothrombin time (International Normalized Ratio), median (IQR) | 1.09 (1.18–1.06) |
| Activated partial thromboplastin time (s), median (IQR) | 25.0 (26.5–23.0) |
Abbreviations: ADAMTS13, a disintegrin and metalloproteinase with thrombospondin motifs 13; IQR, interquartile range; vWF:Ag, von Willebrand factor antigen; vWF:RCo, von Willebrand factor ristocetin cofactor.